Gynecological cancer during pregnancy-From a gyne-oncological perspective.
Katja Stenström BohlinMats BrännströmPernilla Dahm-KählerPublished in: Acta obstetricia et gynecologica Scandinavica (2024)
Gynecological cancer diagnosed during pregnancy requires accurate diagnosis and staging to determine optimal treatment based on gestational age. Cervical and ovarian cancers are the most common and multidisciplinary team collaboration is pivotal. Magnetic resonance imaging and ultrasound can be used without causing fetal harm. In cervical cancer, early-stage treatments can often be delayed until fetal lung maturation and cesarean section is recommended if disease prevails, in combination with a simple/radical hysterectomy and lymphadenectomy. Chemoradiotherapy, the recommended treatment for advanced stages, is not compatible with pregnancy preservation. Most gestational ovarian cancers are diagnosed at an early stage and consist of nonepithelial cancers or borderline tumors. Removal of the affected adnexa during pregnancy is often necessary for diagnosis, though staging can be performed after delivery. In selected cases of advanced cervical and ovarian cancers, neoadjuvant chemotherapy may be an option to allow gestational advancement but only after thorough multidisciplinary discussions and counseling.
Keyphrases
- early stage
- neoadjuvant chemotherapy
- lymph node
- magnetic resonance imaging
- sentinel lymph node
- gestational age
- birth weight
- papillary thyroid
- locally advanced
- weight gain
- preterm birth
- rectal cancer
- childhood cancer
- pregnant women
- squamous cell
- lymph node metastasis
- computed tomography
- pet ct
- squamous cell carcinoma
- young adults
- robot assisted
- pregnancy outcomes
- physical activity
- palliative care
- human immunodeficiency virus
- mass spectrometry
- weight loss
- magnetic resonance